Taurine
13 benefits mapped to clinical evidence across supplements.
Dose per serving from products
3,263 products in our catalogue print how much Taurine a serving holds.
Most common: 500 mg to 1 g, 28% of 3,263 products.
| Dose per serving | Products |
|---|---|
| 25 mg or less | 108 |
| 25 mg to 50 mg | 197 |
| 50 mg to 100 mg | 281 |
| 100 mg to 250 mg | 444 |
| 250 mg to 500 mg | 863 |
| 500 mg to 1 g | 918 |
| 1 g to 2.5 g | 402 |
| over 2.5 g | 50 |
Dose per serving from research
54 study groups in 44 studies say how much Taurine participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 g to 5 g, 39% of 54 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mg or less | 3 |
| 500 mg to 1 g | 4 |
| 1 g to 2.5 g | 19 |
| 2.5 g to 5 g | 21 |
| 5 g to 10 g | 7 |
Commonly used together
13 of 54 study groups took Taurine with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Caffeine | 4 |
Benefit Evidence
Inflammation -59% IL-1β
Catheter infections 0 cases
WBC/CRP improvement
Lower fasting glucose, HbA1c
Lower insulin resistance ~30%
Higher GLP-1, lower glucose
Lower fasting glucose, HbA1c
Lower insulin resistance ~30%
Higher GLP-1, lower glucose
Research sources
Immune support (16)
- Effect of taurolidine on the normal eyelid and conjunctival flora
PubMed ID: 11262606
Topical taurolidine (taurine-derived) reduced eyelid/conjunctival bacterial flora before surgery.
- Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial
PubMed ID: 19309495
Intraoperative taurolidine (a taurine‑derived antimicrobial) markedly lowered peritoneal pro‑/anti‑inflammatory cytokines—strong anti‑inflammatory/immunomodulatory signal for the derivative.
- Impact of TauroLock(™)-HEP500 versus unfractionated heparin for prevention of catheter complications in children with malignancy: a prospective, randomized, controlled study
PubMed ID: 41254792
Pediatric RCT: taurolidine‑citrate locks reduced hs‑CRP and WBC at 6 months (anti‑inflammatory biomarker changes), though clinical infection differences were not significant.
- Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease
PubMed ID: 39447576
Randomized TUDCA trial in progressive MS produced measurable shifts in CD4+ subsets (immune modulation) though without clinical benefit.
- Taurolidine lock reduces recurrent catheter-related bloodstream infections in patients with chronic intestinal failure: A randomized, placebo-controlled trial in a real-world clinical setting
PubMed ID: 40554263
Large RCT: taurolidine (a taurine‑derived antiseptic) catheter lock dramatically reduced bloodstream infections and catheter removals—strong antimicrobial/immune‑related outcome (therapeutic, not nutritional taurine).
- The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury: a double-blind randomized controlled trial
PubMed ID: 34103066
Enteral taurine for 14 days in moderate TBI lowered IL‑6 and improved clinical scores — indicates immunomodulatory/anti‑inflammatory effect.
- Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition
PubMed ID: 29978597
Large RCT in home parenteral nutrition: taurolidine lock substantially reduced CRBSIs (strong clinical infection prevention).
- Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters
PubMed ID: 28890326
Multicenter trial: taurolidine lock markedly lowered catheter infections and dysfunction (robust infection‑prevention evidence for taurine derivative).
- Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial
PubMed ID: 28793993
Taurolidine‑containing lock dramatically reduced catheter bloodstream infections (strong antimicrobial/anti‑infection outcome; agent is taurine‑derived).
- Effect of taurine on attenuating chemotherapy-induced adverse effects in acute lymphoblastic leukemia
PubMed ID: 26148612
Taurine supplementation during ALL maintenance chemo increased white blood cell counts versus placebo (small RCT).
- The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine
PubMed ID: 20223497
Perioperative taurolidine infusion produced pronounced anti‑inflammatory changes (↓IL‑6, ↑IL‑10) after CABG—supports immune/inflammation modulation by taurolidine.
- A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis
PubMed ID: 20207458
Taurolidine‑citrate catheter locks reduced Gram‑negative infections and trended toward fewer bacteremias in hemodialysis patients—clinical antimicrobial effect of a taurine‑related agent.
- Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study
PubMed ID: 18573718
Topical taurine bromamine cream produced ~65% inflammatory acne lesion reduction similar to clindamycin — clinical antibacterial/anti-inflammatory effect attributable to a taurine derivative.
- Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution
PubMed ID: 14993498
Citrate-taurolidine (taurolidine is taurine‑derived) catheter lock eliminated catheter-related sepsis versus heparin—strong infection prevention evidence.
- Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent
PubMed ID: 15126742
N‑chlorotaurine cleared ear infections faster than antibiotic drops—direct antimicrobial/immune-supporting clinical effect in ENT infections.
- Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study
PubMed ID: 14510994
Topical N‑chlorotaurine (taurine derivative) reduced pain and accelerated healing of purulent leg ulcers—antimicrobial/wound‑healing (immune-related) benefit.
Nerve health (11)
- The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury: a double-blind randomized controlled trial
PubMed ID: 34103066
Enteral taurine in TBI patients improved GCS and APACHE II and reduced IL‑6 — direct improvement in neurological outcomes.
- Tinnitus treatment with acamprosate: double-blind study
PubMed ID: 16612523
Acamprosate significantly reduced tinnitus severity vs placebo—meaningful clinical nervous-system symptom improvement (taurine analogue).
- Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study
PubMed ID: 27835719
Adjunctive oral taurine improved psychiatric symptoms in first‑episode psychosis (phase‑2 RCT), indicating CNS symptomatic benefit.
- A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
PubMed ID: 38053196
TUDCA trial (taurine‑conjugate) planned for ALS (neuroprotection) — supports potential nervous system benefit from taurine-related compounds (no results yet).
- Safety and efficacy of taurine as an add-on treatment for tics in youngsters
PubMed ID: 31618495
Large randomized placebo-controlled trial in children with tic disorders: taurine increased chance of large tic improvement — direct CNS clinical benefit.
- Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study
PubMed ID: 19536424
Homotaurine (tramiprosate) slowed hippocampal atrophy and produced modest cognitive benefits in subgroup MRI analyses—strongest indirect evidence from a taurine analogue for CNS protection.
- Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
PubMed ID: 25664595
TUDCA in ALS slowed functional deterioration (randomized pilot), supporting neuroprotective/nervous‑system benefit for a taurine‑conjugated bile acid.
- Effects of Dietary Taurine Supplementation on Blood and Urine Taurine Concentrations in the Elderly Women with Dementia
PubMed ID: 31468402
Taurine supplementation in elderly dementia patients produced cognitive improvements (language/executive) — direct CNS evidence (small study).
- Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
PubMed ID: 32877582
PB‑TURSO (includes taurursodiol) modestly slowed ALS decline — conjugate shows CNS benefit though not plain taurine alone.
- Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
PubMed ID: 33063909
Survival and functional benefits in ALS with PB‑TURSO indicate nervous-system benefit for taurine-conjugate-containing therapy.
- The effect of taurine supplementation on delirium post liver transplantation: A randomized controlled trial
PubMed ID: 36081295
Large RCT in liver transplant patients: oral taurine (2 g/day) markedly reduced delirium incidence — strong clinical neurocognitive benefit.
Heart health (5)
- Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study
PubMed ID: 26781281
Randomized controlled trial: 1.6 g/day taurine for 12 weeks lowered clinic and ambulatory BP and improved vascular function in prehypertensives.
- Nutritional factors for stroke and major cardiovascular diseases: international epidemiological comparison of dietary prevention
PubMed ID: 7919085
Large observational study: higher urinary taurine associated with lower ischemic heart disease mortality (epidemiologic support).
- Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction
PubMed ID: 12075268
Multinutrient supplement including taurine increased myocardial taurine and modestly reduced LVEDV (cannot isolate taurine).
- Normalization of heart rate variability with taurine and meldonium complex in post-infarction patients with type 2 diabetes mellitus
PubMed ID: 31666833
Post-infarction diabetic patients given taurine+meldonium showed improved HRV (better autonomic/ cardiac balance); attribution to taurine alone is confounded.
- The antiendotoxin agent taurolidine potentially reduces ischemia/reperfusion injury through its metabolite taurine
PubMed ID: 20223497
Perioperative taurolidine reduced ischemia/reperfusion arrhythmias after CABG—antiarrhythmic/heart‑protection signal for the taurine‑related agent.
Liver support (6)
- Effect of taurine on synthesis of neutral and acidic sterols and fat absorption in preterm and full-term infants
PubMed ID: 8237845
Taurine improved bile acid excretion and fat absorption and reduced cholesterol synthesis in preterm infants — strong hepatic/biliary metabolic benefits.
- A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
PubMed ID: 27893675
Randomized trial: tauroursodeoxycholic acid (TUDCA, a taurine‑conjugated bile acid) produced liver enzyme improvements non‑inferior to UDCA in PBC patients.
- Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain
PubMed ID: 11524307
Acamprosate-treated alcohol-dependent patients showed improved liver enzyme ratios vs placebo (taurine-derivative effect).
- Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study
PubMed ID: 9840118
TUDCA lowered aminotransferases in HCV-related chronic hepatitis over 6 months — clinically relevant biochemical liver support.
- Effect of taurine on attenuating chemotherapy-induced adverse effects in acute lymphoblastic leukemia
PubMed ID: 26148612
Taurine given to ALL patients improved liver function tests vs placebo (small randomized trial).
- One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation
PubMed ID: 10575563
TUDCA after liver transplant was safe and modestly reduced early cholestasis and lowered early postoperative cholesterol.
Cholesterol (6)
- Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects
PubMed ID: 15221507
Randomized taurine (3 g/day) lowered triglycerides and the atherogenic index in overweight young adults—direct lipid/improvement evidence.
- The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
PubMed ID: 32472292
3 g/day taurine lowered total cholesterol in a small 8‑week RCT in T2D.
- Effect of weight-loss diet combined with taurine supplementation on body composition and some biochemical markers in obese women: a randomized clinical trial
PubMed ID: 32696178
Randomized trial in obese women on calorie‑restriction: 3 g/day taurine for 8 weeks produced greater reductions in total cholesterol and LDL‑C vs diet alone (confounded by calorie restriction).
- The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 32861603
3 g/day taurine for 8 weeks in T2DM reduced total cholesterol and LDL-C in a randomized trial.
- Changes in bile acid subtypes and improvements in lipid metabolism and atherosclerotic cardiovascular disease risk: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial
PubMed ID: 38428740
In a large weight‑loss cohort, decreases in certain tauro‑conjugated bile acids associated with modest reductions in triglycerides and LDL—associative evidence tying taurine‑conjugated bile acids to lipid changes.
- Effect of taurine on synthesis of neutral and acidic sterols and fat absorption in preterm and full-term infants
PubMed ID: 8237845
Taurine reduced cholesterol synthesis and improved bile acid excretion in preterm infants — clinically relevant metabolic effect.
Cell health (6)
- Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
PubMed ID: 32877582
Sodium phenylbutyrate–taurursodiol (contains taurine-conjugated bile acid) slowed ALS functional decline—suggests cellular/neuroprotective effect though product is a combination and conjugate-specific.
- The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury: a double-blind randomized controlled trial
PubMed ID: 34103066
Enteral taurine lowered IL‑6 and improved clinical severity in TBI patients — suggests cytoprotective/anti‑inflammatory effects in injured brain.
- Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease
PubMed ID: 39447576
TUDCA treatment raised circulating bile acids and altered immune cell subsets; TUDCA is a recognized cytoprotective/ER‑stress modulator—good mechanistic support despite lack of clinical effect in this MS trial.
- Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy
PubMed ID: 29687335
Topical eye drop with 0.5% taurine improved tear stability, staining and goblet cell density—direct cellular‑surface protection in the eye.
- Density gradient centrifugation prior to cryopreservation and hypotaurine supplementation improve post-thaw quality of sperm from infertile men with oligoasthenoteratozoospermia
PubMed ID: 23760160
Hypotaurine added to sperm cryopreservation improved mitochondrial potential and reduced DNA fragmentation—direct cell‑protective effects.
- Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
PubMed ID: 25664595
TUDCA (taurine‑conjugated bile acid) added to riluzole slowed functional decline in ALS (pilot RCT) — consistent with cellular protective/neuroprotective effects.
Eye health (4)
- Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study
PubMed ID: 23906760
Eye drops containing taurine (with other actives) reduced dry‑eye symptoms and improved tear tests after 15 days (pilot RCT).
- Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy
PubMed ID: 29687335
Hyaluronic acid eye drops with 0.5% taurine improved BUT, corneal staining and goblet cell density in glaucoma patients (direct ocular surface benefit).
- Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trial
PubMed ID: 15857282
Topical N‑chlorotaurine eye drops reduced symptoms and hastened recovery in adenovirus keratoconjunctivitis—strong clinical eye benefit (taurine derivative).
- Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study
PubMed ID: 12322788
Three-year double-blind trial of a taurine-containing formula slowed visual field loss in retinitis pigmentosa (multi-agent).
Energy & Fatigue (3)
- Taurine attenuates chemotherapy-induced nausea and vomiting in acute lymphoblastic leukemia
PubMed ID: 25323734
Oral taurine (2 g/day) reduced chemotherapy‑related weariness/fatigue in young leukemia patients (double‑blind RCT).
- Effect of gender on the metabolic impact of a commercially available thermogenic drink
PubMed ID: 20508469
Thermogenic drink containing taurine (with caffeine and EGCG) altered resting energy expenditure and FFA AUC; effects cannot be isolated to taurine.
- Possible ameliorative effect of taurine in the treatment of iron-deficiency anaemia in female university students of Gaza, Palestine
PubMed ID: 12431243
Taurine added to oral iron produced greater hemoglobin and ferritin recovery in iron-deficient women—likely reduces anemia-related fatigue.
Blood sugar (3)
- The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
PubMed ID: 32472292
Randomized double‑blind trial: 3 g/day taurine for 8 weeks lowered fasting glucose and insulin in T2D patients (small RCT).
- The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 32861603
Randomized double-blind trial in T2DM: 3 g/day taurine for 8 weeks improved fasting glucose, HbA1c, insulin and HOMA-IR — strong direct evidence.
- The Effects of TRX Suspension Training Combined with Taurine Supplementation on Body Composition, Glycemic and Lipid Markers in Women with Type 2 Diabetes
PubMed ID: 34836211
TRX exercise + taurine (5×500 mg/day) for 8 weeks in T2D improved FBS, HbA1c and HOMA‑IR more than either alone — supports glycemic benefits though combined-intervention limits attribution solely to taurine.
Exercise recovery (3)
- Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease
PubMed ID: 30136291
Taurine 2 g/day reduced muscle cramp frequency, duration and severity in chronic liver disease (symptomatic muscle benefit).
- Additional effects of taurine on the benefits of BCAA intake for the delayed-onset muscle soreness and muscle damage induced by high-intensity eccentric exercise
PubMed ID: 23392882
Small randomized trial: taurine + BCAA reduced DOMS and some markers of muscle damage after intense exercise.
- A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study
PubMed ID: 21899733
Multi-nutrient drink (includes 500 mg taurine) lowered CK and improved strength/power in middle-aged active people, consistent with faster recovery; taurine's role not isolated.
Mood balance (2)
- United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol
PubMed ID: 10787394
Acamprosate reduced early craving and anxiety in a multicentre trial (taurine-derivative; anxiety/mood signal).
- Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study
PubMed ID: 27835719
Adjunctive taurine (4 g/day) for 12 weeks improved psychiatric symptom scores (BPRS) in first‑episode psychosis (phase‑2 RCT).
Antioxidant (2)
- Effect of taurine on attenuating chemotherapy-induced adverse effects in acute lymphoblastic leukemia
PubMed ID: 26148612
Oral taurine during maintenance chemo reduced oxidative‑stress markers (MDA/SOD) vs placebo in a randomized trial.
- Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial
PubMed ID: 26035756
Oral taurine markedly raised plasma taurine and reduced urinary 8‑OHdG (oxidative DNA damage) in elderly hip‑fracture patients.
Blood pressure (1)
- Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study
PubMed ID: 26781281
High‑quality RCT: 1.6 g/day taurine for 12 weeks significantly reduced clinic and ambulatory SBP/DBP versus placebo in prehypertensives.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Taurine
Search all4287 products whose verified label declares Taurine — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.